Retrospective, Real-life Observational, Matched Cohort Evaluation of the Effectiveness of BDP/FOR (Fostair 100/6) and FP/SAL (Seretide 125) in Patients Switching From Seretide to Fostair in UK Primary Care Asthma Management.

Trial Profile

Retrospective, Real-life Observational, Matched Cohort Evaluation of the Effectiveness of BDP/FOR (Fostair 100/6) and FP/SAL (Seretide 125) in Patients Switching From Seretide to Fostair in UK Primary Care Asthma Management.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jun 2012

At a glance

  • Drugs Beclometasone/formoterol; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2012 Actual patient number is 137 according to ClinicalTrials.gov.
    • 07 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Jun 2011 Planned end date changed from 1 Mar 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top